drugset / Trial / NCT01612065

Optimum Misoprostol Dose Prior to Office Hysteroscopy

NCT01612065

Phase 3 Completed 132 enrolled Cairo University
RandomizedParallel-groupDouble-blindTreatment

Summary

Misoprostol is an effective agent for cervical priming before office hysteroscopy, vaginal route is the best, optimum dose not yet known.

Timeline

Start
2012-06
Primary completion
2013-03
Completion
2013-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Misoprostol Other / unclassified 200 ug Intrathecal
Comparator Misoprostol Other / unclassified 400 ug Intrathecal